Nuclea Biotechnologies - Advancing Molecular Oncology |
Last Update : | 14/December/2011 |
Google PR : | 4 |
Internal links : | 13 |
External links : | 1 |
Archive : | Check how did the site look in the past? |
Human-Computer Interaction Resource Network
Nuclea Biotechnologies - Advancing Molecular Oncology |
Last Update : | 14/December/2011 |
Google PR : | 4 |
Internal links : | 13 |
External links : | 1 |
Archive : | Check how did the site look in the past? |
Site IP address : | 208.125.167.118 |
Server type : | Apache/2.2.3 (CentOS) |
Powered by : | PHP/5.1.6 |
DNS 1 : | ns77.domaincontrol.com |
DNS 2 : | ns78.domaincontrol.com |
MX Domain 1 : | nucleabio.com.s6a1.psmtp.com |
MX Domain 2 : | nucleabio.com.s6a2.psmtp.com |
MX Domain 3 : | nucleabio.com.s6b1.psmtp.com |
MX Domain 4 : | nucleabio.com.s6b2.psmtp.com |
Alexa rank : | 14,794,892 |
Description : | There are 14,794,891 sites with a better three-month global Alexa traffic rank than Nucleabio.com. |
nuclea biotechnologies | 22.36% |
boston medical center bloch nicholas | 13.58% |
nicholas bloch bmc | 13.04% |
nuclea acid research | 4.70% |
nuclea | 4.34% |
cancer diagnosis tools | 0.11% |
Quantcast rank : | 0 | Average US daily traffic : | 0 |
Compete rank : | 0 |
Average daily unique visitors : | 0 |
MyWot rank : | 0 |
Trustworthiness : | 0 |
Vendor reliability : | 0 |
Privacy : | 0 |
Child safety : | 0 |